MB "Solimedica" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 0 |
| - |
| -1,790 |
| -1,790 |
| - |
| - |
| - |
| -1,789 |
| 6,207 |
| 14,912 |
| 13,721 |
| - |
| -3.47 |
| - |
| - |
| - |
| -1,790 |
| 2025 |
|---|
| 11,811 |
| - |
| -7,038 |
| -7,195 |
| - |
| 97.34 |
| -60.92 |
| -8,502 |
| 9,803 |
| 12,024 |
| 10,760 |
| 0.08 |
| -1.15 |
| - |
| - |
| -59.59 |
| -7,038 |
| 2025 |
|---|
| 11,811 |
| - |
| -7,038 |
| -7,195 |
| - |
| 97.34 |
| -60.92 |
| -8,502 |
| 9,803 |
| 12,024 |
| 10,760 |
| 0.08 |
| -1.15 |
| - |
| - |
| -59.59 |
| -7,038 |
Turnover (€)
2025
Turnover (€)
11,811 €- *
Sales per employee (€)
-Profit before tax (€)
-7,038 €-293 % *
Net Profit (€)
-7,195 €-302 % *
Profit per employee (€)
-Total profitability (%)
97.34 %- *
Net profitability (%)
-60.92 %- *
Equity (€)
-8,502 €-375 % *
Amounts Payable And Liabilities (€)
9,803 €58 % *
Non-current Assets (€)
12,024 €-19 % *
CurrentAssets (€)
10,760 €-22 % *
Working capital requirement
0.08 - *
Debt-to-equity ratio
-1.15 66.86 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-59.59 %- *
EBIT (€)
-7,038 €-293 % *
